Anastrozole should, therefore, now be considered a valid alternative option to tamoxifen for adjuvant hormonal treatment in all postmenopausal women with hormone receptor positive early breast cancer 5 mg tamoxifen study Telmisartan works by blocking the vasoconstrictor and aldosterone secretory effects of angiotensin II
Één reactie
Anastrozole should, therefore, now be considered a valid alternative option to tamoxifen for adjuvant hormonal treatment in all postmenopausal women with hormone receptor positive early breast cancer 5 mg tamoxifen study Telmisartan works by blocking the vasoconstrictor and aldosterone secretory effects of angiotensin II